期刊文献+

阿霉素心脏毒性中的细胞凋亡 被引量:2

Apoptosis in Adriamycin Cardiotoxicity
在线阅读 下载PDF
导出
摘要 阿霉素(ADR)在临床上广泛用于治疗多种恶性肿瘤,其作用无可争议。但是ADR长期使用可以出现不可逆转的心肌病、充血性心力衰竭(CHF)而使它的应用受到限制。ADR心脏毒性的发病机制仍有争议。越来越多的证据表明,细胞凋亡在ADR心肌病的发病过程中起关键性作用。这里我们主要讨论阿霉素心脏毒性中的细胞凋亡的研究最新进展。 Adriamycin(ADR)play an undisputed key role in the treatment of many neoplastic diseases,but chronic administration of ADR induces irreversible cardiomyopathy and congestive heart failure(CHF)usually refractory to common medications.The mechanisms responsible for the cardiotoxic effect of ADR have been extremely controversial.It is becoming increasingly clear that apoptosis of myocardial cells plays a critical role in the onset of cardiomyopathy induced by ADR.Here we describe the most recent advances about apoptosis of myocardial cells induced by ADR.
出处 《心血管病学进展》 CAS 2005年第2期206-209,共4页 Advances in Cardiovascular Diseases
关键词 心脏毒性 阿霉素 细胞凋亡 ADR 心肌病 治疗 逆转 限制 Adriamycin Cardiotoxicity Apoptosis
  • 相关文献

参考文献1

二级参考文献11

  • 1夏奕明 朱莲珍.血和组织中谷胱甘肽过氧化物酶活力的测定方法[J].卫生研究,1987,16(4):29-29.
  • 2Ewer MS,Gibs HR,Swafford J,et al. Cardiotoxicity in patients receiving trastuzumab (Herceptin):primary toxicity, synergistic or sequential stress, or surveillance artifact [J]. Semin Oncol,1999,26(4 supple 12):99- 101.
  • 3陈顺志 金有余 李常淳.过氧化脂质 TBA显色的三种办法比较 [J].临床检验杂志,1984,2(4):8-8.
  • 4Feldman AM,Lorell BH,Reis SE. Trastuzumab in the treatment of metastatic breast cancer: anticancer therapy versus cardiotoxicity [J]. circulation,2000,102(3):272- 274.
  • 5Sawyer DB, Zuppinger C,Miller TA,et al. Modulation of anthracycline-induced myofibrillar disarray in rat ventricular myocytes by neuregulin-1beta and anti-erbB2:potential mechanism for trastuzumab-induced cardiotoxicity.Circulation [J].Circulation,2002,105(13):1551- 1554.
  • 6Ozcelik C, Erdmann B,Pilz B,et al. Conditional mutation of the ErbB2(HER2) receptor in cardiomuocytes leads to dilated cardiomyopathy [J]. Proc Natl Acad Sci USA,2002,99(13):8880- 8885.
  • 7Crone SA,Zhao YY,Minamisaw S,et al. ErbB2 is essential in the prevention of dilated cardiomyopathy [J]. Nature Medicine,2002,8(5):459- 465.
  • 8Dorr RT. Cytoprotective agents for anthracyclines [J]. Semin Oncol,1996, 23(4 Suppl 8):23- 24.
  • 9Schneider JW,Chang AY,Garratt A. Trastuzumab cardiotoxicity:Speculations regarding pathophysiology and targets for further study [J]. Semin Oncol,2002,29(3 Suppl 11):22- 28.
  • 10Nakamura T,Ueda Y,Juan Y,et al. Fas-mediated apoptosis in adria mycin-induced cardiomyopathy in rats:in vivo study [J]. Circulation,2000, 102(5):572- 578.

共引文献6

同被引文献56

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部